Expert Consensus on the Clinical Application of Tianma Xingnao Capsule in the Treatment of Vascular Cognitive Impairment and Neuropathic Headache  

作　　者：Yaming LIN Wei CHEN Linyuan HU Zhifang DUAN 

机构地区：[1]Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming 650021, China

出　　处：《Medicinal Plant》2021年第5期75-80,共6页药用植物：英文版

基　　金：Funding from Yunnan Chinese Medicine Clinical Key Discipline,Yunnan University of Traditional Chinese Medicine Encephalopathy School Construction Project(30372103700).

摘　　要：The prescription of Tianma Xingnao Capsule is composed of Gastrodiae Rhizoma,Pheretima,Acori Tatarinowii Rhizoma,Polygalae Radix,Rehmanniae Radix Praeparata,and Cistanches Herba.It has effects of nourishing liver and kidney,dredging collaterals and relieving pain.More than 20 years of clinical application and evidence-based medical research have shown that Tianma Xingnao Capsule has a significant therapeutic effect on vascular cognitive impairment and neuropathic headache.In order to further guide the proper clinical use of this prescription,the consensus expert group conducted a comprehensive analysis of the prescription of Tianma Xingnao Capsule.Combining the existing evidence-based medicine evidence and the experience of clinical experts,this consensus report standardized the usage,dosage,duration and safety of Tianma Xingnao Capsule in the treatment of vascular cognitive impairment and neuropathic headache.It is expected to provide a theoretical basis for clinically reasonable and safe use of Tianma Xingnao Capsule.

关 键 词：Tianma Xingnao Capsule Vascular cognitive impairment(VCI) Neuropathic headache Expert consensus 

分 类 号：R28[医药卫生—中药学]